TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03000673

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin
Description: Specified dose of Enoxaparin on specified days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin
Description: Specified dose of Enoxaparin on specified days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin
Description: Specified dose of Enoxaparin on specified days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin (UFH)
Description: Specified dose of UFH on specified days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin (UFH)
Description: Specified dose of UFH on specified days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin (UFH)
Description: Specified dose of UFH on specified days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin (UFH)
Description: Specified dose of UFH on specified days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BMS-986177
Description: Specified dose of BMS-986177 on specified day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BMS-986177
Description: Specified dose of BMS-986177 on specified day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BMS-986177
Description: Specified dose of BMS-986177 on specified day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BMS-986177
Description: Specified dose of BMS-986177 on specified day
Study: NCT00267111

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Eucerin plus
Description: 1g, single application

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amethocaine gel 4%
Description: 1 g, single application
Study: NCT02270073

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy of trainee therapists
Description: In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 25 sessions, while on average every fourth is supervized by an CBT expert therapist.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavior therapy of trainee therapists
Description: In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 25 sessions, while on average every fourth is supervized by an CBT expert therapist.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive behavior therapy of trainee therapists
Description: In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 25 sessions, while on average every fourth is supervized by an CBT expert therapist.
Study: NCT04100200

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mixed berries
Description: Strawberry and red raspberry

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: FOS
Description: Fructo-oligosaccharide

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Placebo similar in color to mixed berry supplement without any polyphenols

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Combination
Description: Mixed berry composite + FOS
Study: NCT05908890

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Denture Adhesive
Description: Adhesive will be applied to the partial denture(s) by a dental professional separate from the examiner and subject.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fixodent True Feel Denture Adhesive
Description: Adhesive will be applied to the partial denture(s) by a dental professional separate from the examiner and subject.
Study: NCT02368002

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss therapy
Description: All participants start with behavioral weight loss therapy which consists of 20 weekly meetings wtih a weight loss coach. Session components will include weekly weigh-in, discussion of progress and challenges and discussion of scheduled session topic. Dietary goals and physical activity goals are set. After their first session, participants are randomized to have their weight assessed at either their 3rd session or their 7th session. Both the participant and their coach are blinded to the randomization. If the participant has lost the expected amount of weight, they continue with behavioral weight loss therapy for the full 20 session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Portion-controlled meals
Description: Participants continue with behavioral weight loss therapy, but this is augmented with portion-controlled meals (PCM). Adherence to energy intake goals is facilitated by consuming pre-prepared meals specifically designed to meet caloric intake guidelines. PCMs reduce individuals' motivationally- and self-regulatory-dependent planning and decision making around eating. PCMs also serve as a teaching tool regarding the amount and type of food people should eat in order to produce weight loss.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance-based treatment
Description: Switching the therapeutic approach to an enhanced behavioral weight loss therapy teaching acceptance-based behavioral skills theoretically addresses the root problem of many weight loss challenges and boosts long-term capacity for self-regulation. Acceptance based strategies are designed to help participants identify and internalize values and lasting commitment to behavior consistent with these values. The strategies focus on increasing people's ability to forgo more pleasurable options (e.g., hedonic pleasure of food) in favor of behavior that is distinctly less pleasurable or even aversive (remaining hungry, anxious, bored). The inability to tolerate such distress is directly associated with failure of self-regulation.
Study: NCT04957732

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (SoC)
Description: SoC consisted of irrigation with normal saline, using the same proprietary abscess irrigation tip as the Irrisept arm. SoC was used at the initial visit and at each subsequent 48-hour visit interval (up to 96 hours) until abscess healing.
Study: NCT01932086

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Brown rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Brown rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study: NCT02747433

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robot-Assisted Therapy (RT)
Description: Highly repetitive robot-assisted therapy for paretic arm with Armeo (1 hr sessions, 3x week for 3 weeks) followed by robot-assisted therapy for hand motions with Amadeo (3x week for 3 weeks). Robot training to be accompanied with ALPS motor learning program directed toward UE self management and transfer of training to daily activities in home \& community.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robot & Task-Oriented Training (RT-TOT)
Description: Highly repetitive robot-assisted therapy for paretic arm with Armeo (30 min sessions, 3x week for 3 weeks) followed by robot-assisted therapy for hand motions with Amadeo (3x week for 3 weeks). Task oriented training will be delivered for remaining 30 mins of each treatment session. Robot and task oriented training to be accompanied with ALPS motor learning program directed toward UE self management and transfer of training to daily activities in home \& community.
Study: NCT04179409

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amondys 45
Description: This drug is used to target skipping of exon 45 of the dystrophin gene.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exondys 51
Description: This drug is used to target skipping of exon 51 of the dystrophin gene.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vyondys 53
Description: This drug is used to target skipping of exon 53 of the dystrophin gene.
Study: NCT03416062

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remaxol®
Description: Solution for intravenous infusions, containing succinate, methionine, inosine, and nicotinamide in 400 ml glass bottle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remaxol®
Description: Solution for intravenous infusions, containing succinate, methionine, inosine, and nicotinamide in 400 ml glass bottle

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ringer's Solution
Description: Solution for intravenous infusion, 400 or 800 ml

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ringer's Solution
Description: Solution for intravenous infusion, 400 or 800 ml
Study: NCT01236547

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib Hydrochloride
Description: Given PO

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study: NCT03466593

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Description: Prehabilitation concerning eating, smoking, drinking and physical activity

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine care
Description: Preoperative information
Study: NCT01932086

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Black rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Black rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study: NCT03466593

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extra early mobilization
Description: Mobilization the day of surgery

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard mobilization
Description: Mobilization the day after surgery
Study: NCT01932086

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Black rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Black rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Black rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bread
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study: NCT04250077

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Reinforcement And Family Training (CRAFT)
Description: Community Reinforcement Approach and Family Training (CRAFT) is a scientifically based intervention designed to help concerned significant others (CSOs) to engage treatment-refusing substance abusers into treatment. This new intervention method was developed with the belief that the CSO can play a powerful role in helping to engage the substance user in treatment. It is often the substance user who reports that family pressure or influence is the reason sought treatment. CSOs benefit by becoming more independent and reducing their depression, anxiety and anger symptoms even if their loved one does not enter treatment.~CRAFT uses a positive approach versus confrontation, emphasizing learning new skills to cope with old problems. Some components include: how to stay safe, outlining the context in which substance abusing behavior occurs, teaching CSOs how to use positive reinforcers (rewards) and how to let the substance user suffer the natural consequences for their using behavior.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Reinforcement And Family Training (CRAFT)
Description: Community Reinforcement Approach and Family Training (CRAFT) is a scientifically based intervention designed to help concerned significant others (CSOs) to engage treatment-refusing substance abusers into treatment. This new intervention method was developed with the belief that the CSO can play a powerful role in helping to engage the substance user in treatment. It is often the substance user who reports that family pressure or influence is the reason sought treatment. CSOs benefit by becoming more independent and reducing their depression, anxiety and anger symptoms even if their loved one does not enter treatment.~CRAFT uses a positive approach versus confrontation, emphasizing learning new skills to cope with old problems. Some components include: how to stay safe, outlining the context in which substance abusing behavior occurs, teaching CSOs how to use positive reinforcers (rewards) and how to let the substance user suffer the natural consequences for their using behavior.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: We The Village Peer Community Forum
Description: An online peer support forum with other CSOs. Members of the forum post questions or comments to weekly peer-led discussions and receive responses and feedback from other CSO forum members. Members typically express concerns regarding their IP's wellbeing and ask other members to share any strategies they have employed when dealing with their IPs. Interactions typically, are based either in 12-Step strategies members have learned (usually through Al-Anon or Nar-Anon Family Groups or Family Training Workshops provided by treatment programs) or in CRAFT skills learned (usually from treatment programs or other We The Village members). A staff member from We The Village monitors forum interactions to ensure members are interacting respectfully.
Study: NCT00315757

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mapatumumab
Description: 10 mg/kg IV (in the vein), on day 1 of each 21-day cycle. Number of cycles: Treatment will continue for up to 17 cycles, or until disease progression or unacceptable toxicity.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mapatumumab
Description: 20 mg/kg IV (in the vein), on day 1 of each 21-day cycle. Number of cycles: Treatment will continue for up to 17 cycles, or until disease progression or unacceptable toxicity.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bortezomib
Description: 1.3 mg/m\^2 IV (in the vein), twice weekly for two weeks (Days 1, 4, 8, and 11) of each 21-day cycle. Number of cycles: Treatment will continue for up to 17 cycles, or until disease progression or unacceptable toxicity.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: 1.3 mg/m\^2 IV (in the vein), twice weekly for two weeks (Days 1, 4, 8, and 11) of each 21-day cycle. Number of cycles: Treatment will continue for up to 17 cycles, or until disease progression or unacceptable toxicity.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: 1.3 mg/m\^2 IV (in the vein), twice weekly for two weeks (Days 1, 4, 8, and 11) of each 21-day cycle. Number of cycles: Treatment will continue for up to 17 cycles, or until disease progression or unacceptable toxicity.
Study: NCT04148144

Intervention type: OTHER
Intervention: No intervention included
Description: No intervention included

Intervention type: OTHER
Intervention: No intervention included
Description: No intervention included
Study: NCT03452748

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FTIR spectroscopy
Description: FTIR spectroscopy examines collagen fibers in the excised membranes
Study: NCT02150902

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wide area circumferential catheter ablation
Description: All subjects in the control arm of the trial will undergo wide area circumferential catheter ablation (WACA; lesions delivered 1-2 cm away from the pulmonary vein ostium) around all four pulmonary veins to the endpoint of electrical isolation (demonstrated by entry and exit block using differential pacing). Catheter ablation will be performed using contact force (CF) and electroanatomical mapping system guidance (average CF \>10g, FTI \> 500 g-sec and minimum ablation duration \>10 sec). Dormant pulmonary vein conduction will be tested using adenosine, after completion of the lesion set, and additional lesions will be delivered to eliminate dormant PV conduction.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Augmented- wide area circumferential ablation procedure
Description: Subjects in this group will have WACA performed as described for WACA. Following completion of the WACA procedure a second set of circumferential ablation lesions will be delivered around the first set of ablation lesions. The ablation catheter tip will be positioned at each of the ablation lesions along the first WACA line and then moved away (from the PV ostia) until healthy, non ablated tissue is recorded from the catheter tip. Energy will be delivered using CF and FTI data as described previously. Once the first WACA ablation line has been completely duplicated the procedure will be deemed complete. In case PV isolation is not achieved after the first WACA lesion set repeat electrophysiologic testing will be performed to determine whether the augmented-WACA procedure was successful in achieving PV isolation.
Study: NCT04957732

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Irrisept Delivery System
Description: Irrisept is a manual, self-contained irrigation device capable of producing 7-8 psi of pressure for effective wound cleansing and irrigation. Irrisept contents include the Chlorhexidine Gluconate (CHG) solution, a 450 mL bottle, and Irriprobe applicator or an abscess irrigation tip. The bottle design allows users to control the pressure of the solution through manual bottle compression. The device had an option for use with an Irriprobe applicator or an abscess irrigation tip. Irrisept was used at the initial visit and at each subsequent 48-hour visit interval (up to 96 hours) until abscess healing.
Study: NCT01932086

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bread
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study: NCT01466296

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chaotic Perturbation
Description: Each subject will undergo 36 intervention sessions, 3 times per week over 12 weeks. Each session will last up to 45 minuets, depending on the subject's endurance. During each session the subject will perform basic stretching and muscle strengthening, then wear the random shoes and perform a set of exercises following specific verbal tasks, e.g., Walk 5 strides forward, or, Walk to the right side until I ask you to stop. During this stage of walking the device will impose perturbations in the range tolerated by the subject. The therapist will make a written report of each session.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dummy not active shoes
Description: Each subject will undergo 36 intervention sessions, 3 times per week over 12 weeks. Each session will last up to 45 minuets, depending on the subject's endurance. During each session the subject will perform basic stretching and muscle strengthening, then wear the dummy shoes and perform a set of exercises following specific verbal tasks, e.g., Walk 5 strides forward, or, Walk to the right side until I ask you to stop. During this stage of walking the device will not impose perturbations. The therapist will make a written report of each session.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Treadmill training
Description: Each subject will undergo 36 intervention sessions, 3 times per week over 12 weeks. Each session will last up to 45 minuets, depending on the subject's endurance. During each session the subject will exercise basic stretching and muscle strengthening, then walk on the treadmill. A physiotherapist according the subject's rate of improvement will determine the increase in treadmill velocity and slope. The therapist will make a written report after each session.